Replies to post #366799 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Figure it gets you to an enterprise value of approximately $18.5 billion, including assumption of debt. I believe that the largest biotech buyout over the past several years is roughly $20 billion or so, and NVCR has a MC of about $14 billion, which sets a floor. So we’re probably somewhere between.